Found 6 Enz. Inhib. hit(s) with all data for entry = 10955 TargetRAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D](Homo sapiens (Human))
Hanmi Pharm.
US Patent
Hanmi Pharm.
US Patent
Affinity DataIC50: 21nMAssay Description:ormula (I) bis-hydrochloride salt prepared in Example 2 (hereinafter referred to as “Compound⋅2HCl”) was tested for inhibitory activity against...More data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:ormula (I) bis-hydrochloride salt prepared in Example 2 (hereinafter referred to as “Compound⋅2HCl”) was tested for inhibitory activity against...More data for this Ligand-Target Pair
Affinity DataIC50: 107nMAssay Description:ormula (I) bis-hydrochloride salt prepared in Example 2 (hereinafter referred to as “Compound⋅2HCl”) was tested for inhibitory activity against...More data for this Ligand-Target Pair
3D Structure (crystal)Affinity DataIC50: 111nMAssay Description:ormula (I) bis-hydrochloride salt prepared in Example 2 (hereinafter referred to as “Compound⋅2HCl”) was tested for inhibitory activity against...More data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase [Y340D,Y341D](Homo sapiens (Human))
Hanmi Pharm.
US Patent
Hanmi Pharm.
US Patent
Affinity DataIC50: 138nMAssay Description:ormula (I) bis-hydrochloride salt prepared in Example 2 (hereinafter referred to as “Compound⋅2HCl”) was tested for inhibitory activity against...More data for this Ligand-Target Pair
Affinity DataIC50: 392nMAssay Description:ormula (I) bis-hydrochloride salt prepared in Example 2 (hereinafter referred to as “Compound⋅2HCl”) was tested for inhibitory activity against...More data for this Ligand-Target Pair
